Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Neogen Corporation develops, manufactures, and markets various products for food and animal safety worldwide. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $468.5M | $527.2M | $822.4M | $924.2M | $894.7M |
| Gross profit | $215.1M | $243.0M | $406.0M | $463.9M | $421.4M |
| Operating income | $74.2M | $58.6M | $37.5M | $58.7M | -$1.1B |
| Net income | $60.9M | $48.3M | -$22.9M | -$9.4M | -$1.1B |
| Diluted EPS | $0.57 | $0.45 | -$0.12 | -$0.04 | -$5.03 |
| Operating cash flow | $81.1M | $68.0M | $41.0M | $35.3M | $58.2M |
| Free cash flow | — | — | — | — | — |
| Gross margin | 45.9% | 46.1% | 49.4% | 50.2% | 47.1% |
| Operating margin | 15.8% | 11.1% | 4.6% | 6.3% | -118.6% |
| Net margin | 13.0% | 9.2% | -2.8% | -1.0% | -122.1% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $236.8M | $217.0M | $231.3M | $221.0M | $225.4M | $209.2M | $224.7M | $211.2M |
| Gross profit | $113.5M | $104.9M | $113.3M | $110.3M | $92.8M | $95.0M | $106.7M | $99.0M |
| Operating income | $13.0M | $2.3M | -$457.5M | $5.4M | -$611.2M | -$16.1M | -$5.4M | -$3.3M |
| Net income | -$5.4M | -$12.6M | -$456.3M | -$10.9M | -$612.3M | $36.3M | -$15.9M | -$17.0M |
| Diluted EPS | -$0.02 | -$0.06 | -$2.10 | -$0.05 | -$2.82 | $0.17 | -$0.07 | -$0.08 |
| Operating cash flow | $26.7M | -$17.9M | $40.3M | $19.5M | $16.4M | $10.9M | $19.4M | $22.7M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 47.9% | 48.4% | 49.0% | 49.9% | 41.2% | 45.4% | 47.5% | 46.9% |
| Operating margin | 5.5% | 1.0% | -197.8% | 2.4% | -271.1% | -7.7% | -2.4% | -1.6% |
| Net margin | -2.3% | -5.8% | -197.3% | -4.9% | -271.6% | 17.4% | -7.1% | -8.0% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-03 | Moylan John Patrick· Chief Accounting Officer | Tax withholding | 2,553 | $8.75 | $22,338.75 | filing |
| 2026-05-18 | Rocklin Amy M· Former Chief Legal Officer | Option exercise | 35,183 | $9.29 | $326,850.07 | filing |
| 2026-05-18 | Rocklin Amy M· Former Chief Legal Officer | Tax withholding | 10,241 | $9.29 | $95,138.89 | filing |
| 2026-05-04 | Moylan John Patrick· Chief Accounting Officer | Option exercise | 4,558 | $9.53 | $43,437.74 | filing |
| 2026-05-04 | Moylan John Patrick· Chief Accounting Officer | Tax withholding | 1,568 | $9.53 | $14,943.04 | filing |
| 2026-05-01 | Stacey Jennifer Evans· Chief Legal Officer | Award | 39,349 | $9.53 | $374,995.97 | filing |
| 2026-02-17 | Nassif Mikheal· CEO | Buy | 23 | $10.94 | $251.62 | filing |
| 2026-02-02 | Nassif Mikheal· CEO | Buy | 24 | $10.00 | $239.99 | filing |
| 2026-01-26 | Nassif Mikheal· CEO | Buy | 25 | $9.86 | $246.38 | filing |
| 2026-01-16 | Nassif Mikheal· CEO | Buy | 137 | $9.33 | $1,278.88 | filing |
| 2026-01-07 | Ranalli Tamara A.· Senior Vice President | Award | 50,813 | $7.38 | $374,999.94 | filing |
| 2026-01-07 | Ranalli Tamara A.· Senior Vice President | Award | 50,813 | $7.38 | $374,999.94 | filing |
| 2026-01-07 | Ranalli Tamara A.· Senior Vice President | Award | 50,813 | $7.38 | $374,999.94 | filing |
| 2025-12-01 | Naemura David H.· Former CFO | Option exercise | 12,912 | $5.98 | $77,213.76 | filing |
| 2025-12-01 | Naemura David H.· Former CFO | Tax withholding | 3,548 | $5.98 | $21,217.04 | filing |
| 2025-11-03 | Riggsbee Richard Bryan· CFO | Award | 178,855 | $6.29 | $1.1M | filing |
| 2025-11-03 | Nassif Mikheal· CEO | Buy | 177 | $6.25 | $1,106.25 | filing |
| 2025-10-27 | ADENT JOHN EDWARD· Former CEO | Option exercise | 38,759 | $6.19 | $239,918.21 | filing |
| 2025-10-27 | Naemura David H.· Chief Financial Officer | Option exercise | 15,504 | $6.19 | $95,969.76 | filing |
| 2025-10-27 | Jones Douglas Edward· Former COO | Option exercise | 15,504 | $6.19 | $95,969.76 | filing |
| 2025-10-27 | Rocklin Amy M· Chief Legal Officer | Option exercise | 9,474 | $6.19 | $58,644.06 | filing |
| 2025-10-27 | ADENT JOHN EDWARD· Former CEO | Tax withholding | 8,527 | $6.19 | $52,782.13 | filing |
| 2025-10-27 | Naemura David H.· Chief Financial Officer | Tax withholding | 4,261 | $6.19 | $26,375.59 | filing |
| 2025-10-27 | BOEHM WILLIAM T | Option exercise | 3,553 | $6.07 | $21,566.71 | filing |
| 2025-10-27 | Jones Douglas Edward· Former COO | Tax withholding | 3,481 | $6.19 | $21,547.39 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.